Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Psorcast Mobile Study is a clinical trial aimed at understanding how symptoms of psoriasis and psoriatic arthritis can vary among patients. This study uses a smartphone app to make it easy for participants to report their symptoms by answering questionnaires and using sensors on their devices. By gathering this information, researchers hope to learn more about these conditions and improve patient care.
To participate in the study, individuals must be at least 18 years old and have a compatible iPhone or iPod Touch that runs a specific version of the software. It's important that participants can read and understand the language used in the study. During the trial, participants will use the app to track their symptoms regularly. If you're interested in contributing to research that could help many others with similar conditions, this study might be a great opportunity for you!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult age 18 and older who consent to participate in the study
- • Own a compatible iPhone or iPod Touch device running iOS 12.2 or above
- • Be able to read and understand an official language of the country of participation
- Exclusion Criteria:
- • Age 17 years or younger
- • Not a resident of the a country where the app is approved for use
- • Not have a personal (i.e., not shared) iPhone (4s or newer running iOS 8.0 or later)
- • Not be able to read and understand an official language of the country of participation
About Sage Bionetworks
Sage Bionetworks is a nonprofit research organization dedicated to advancing biomedical research through innovative data-sharing and collaborative approaches. By leveraging cutting-edge technology and open-source methodologies, Sage Bionetworks fosters a robust ecosystem for the development of transformative therapies, particularly in the fields of cancer, neuroscience, and chronic diseases. The organization emphasizes the integration of diverse data types, including genomic, clinical, and patient-reported outcomes, to enhance the understanding of complex health conditions and facilitate the translation of scientific discoveries into meaningful clinical applications. Through partnerships with academic institutions, industry leaders, and patient communities, Sage Bionetworks aims to accelerate the pace of discovery and improve healthcare outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Solveig Sieberts, Ph.D
Principal Investigator
Sage Bionetworks
Jose Scher, MD
Principal Investigator
NYU Langone Medical Center
Joseph Merola, MD, MMSc
Principal Investigator
Brigham and Women's Hospital & Harvard Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials